BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27245420)

  • 1. PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle.
    Zhang T; Braun U; Leitges M
    Cell Cycle; 2016 Jul; 15(14):1844-54. PubMed ID: 27245420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreas-specific deletion of protein kinase D attenuates inflammation, necrosis, and severity of acute pancreatitis.
    Yuan J; Chheda C; Piplani H; Geng M; Tan G; Thakur R; Pandol SJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165987. PubMed ID: 33039594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion.
    Chen LA; Li J; Silva SR; Jackson LN; Zhou Y; Watanabe H; Ives KL; Hellmich MR; Evers BM
    J Biol Chem; 2009 Jan; 284(4):2459-71. PubMed ID: 19028687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase D3 promotes neutrophil migration during viral infection.
    Veazey JM; Wong GS; Eliseeva SI; Smyth TR; Chapman TJ; Lim K; Kim M; Georas SN
    Immunol Cell Biol; 2023 Feb; 101(2):130-141. PubMed ID: 36318273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists.
    Rey O; Yuan J; Young SH; Rozengurt E
    J Biol Chem; 2003 Jun; 278(26):23773-85. PubMed ID: 12676944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.
    LaValle CR; Zhang L; Xu S; Eiseman JL; Wang QJ
    Mol Cancer Ther; 2012 Jul; 11(7):1389-99. PubMed ID: 22532599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.
    Liu Y; Li J; Ma Z; Zhang J; Wang Y; Yu Z; Lin X; Xu Z; Su Q; An L; Zhou Y; Ma X; Yang Y; Wang F; Chen Q; Zhang Y; Wang J; Zheng H; Shi A; Yu S; Zhang J; Zhao W; Chen L
    Cancer Med; 2019 Feb; 8(2):729-741. PubMed ID: 30652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes.
    Matthews SA; Liu P; Spitaler M; Olson EN; McKinsey TA; Cantrell DA; Scharenberg AM
    Mol Cell Biol; 2006 Feb; 26(4):1569-77. PubMed ID: 16449666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase D3 activation and phosphorylation by signaling through G alpha q.
    Yuan J; Rey O; Rozengurt E
    Biochem Biophys Res Commun; 2005 Sep; 335(2):270-6. PubMed ID: 16081049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protein kinase D3 by signaling through Rac and the alpha subunits of the heterotrimeric G proteins G12 and G13.
    Yuan J; Rey O; Rozengurt E
    Cell Signal; 2006 Jul; 18(7):1051-62. PubMed ID: 16198087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.
    Hao Q; McKenzie R; Gan H; Tang H
    Anticancer Res; 2013 Feb; 33(2):393-9. PubMed ID: 23393329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual C1 domains of PKD3 in phorbol ester-induced plasma membrane translocation of PKD3 in intact cells.
    Anderson G; Chen J; Wang QJ
    Cell Signal; 2005 Nov; 17(11):1397-411. PubMed ID: 15927450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase D 3 is localized in vesicular structures and interacts with vesicle-associated membrane protein 2.
    Lu G; Chen J; Espinoza LA; Garfield S; Toshiyuki S; Akiko H; Huppler A; Wang QJ
    Cell Signal; 2007 Apr; 19(4):867-79. PubMed ID: 17196367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells.
    Li L; Hua L; Fan H; He Y; Xu W; Zhang L; Yang J; Deng F; Zeng F
    J Cancer; 2019; 10(25):6395-6404. PubMed ID: 31772672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of protein kinase D 3 during mouse development.
    Ellwanger K; Pfizenmaier K; Lutz S; Hausser A
    BMC Dev Biol; 2008 Apr; 8():47. PubMed ID: 18439271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the protein kinase D (PKD) family during mouse embryogenesis.
    Oster H; Abraham D; Leitges M
    Gene Expr Patterns; 2006 Apr; 6(4):400-8. PubMed ID: 16377259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes.
    Chen J; Lu G; Wang QJ
    Mol Pharmacol; 2005 Jan; 67(1):152-62. PubMed ID: 15496505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
    Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ
    PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.
    Durand N; Borges S; Storz P
    Cell Mol Life Sci; 2015 Nov; 72(22):4369-82. PubMed ID: 26253275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J; Deng F; Li J; Wang QJ
    Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.